ExploreWatchlistsPricing
  1. US-listed companies
  2. ABBOTT LABORATORIES
  3. Financials
  4. Operating income

ABBOTT LABORATORIES (ABT)

Market cap
$165.9B
P/E ratio
25.7x
SummaryFinancials
Period EndOperating income (Million USD)YoY (%)
Dec 31, 20258,053+17.99%
Dec 31, 20246,825+5.36%
Dec 31, 20236,478-22.53%
Dec 31, 20228,362-0.75%
Dec 31, 20218,425+57.27%
Dec 31, 20205,357+18.20%
Dec 31, 20194,532+24.16%
Dec 31, 20183,650+111.47%
Dec 31, 20171,726-45.81%
Dec 31, 20163,185+11.09%
Dec 31, 20152,867+9.05%
Dec 31, 20132,629-54.29%
Dec 31, 20115,752-5.51%
Dec 31, 20106,088

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat